HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiovascular differences between phenylpropanolamine and its related norephedrine isomers in the rat.

Abstract
Various studies have confused the norephedrine and norpseudoephedrine isomers with phenylpropanolamine (PPA, d,l-norephedrine). This confusion has led us to investigate the pharmacological activity of the norephedrine (NOR) and norpseudoephedrine (NORP) isomers in the cardiovascular system of the urethane:chloralose anesthetized rat. Following intravenous administration, in a cumulative-dose fashion, l-NOR and PPA were the most potent compounds at increasing arterial blood pressure, while d-NOR, d-NORP, and l-NORP were relatively inactive at the doses tested (0.31-10 mg/kg). Prior reserpinization did not significantly shift the cumulative dose-response curves for l-NOR and PPA. Repetitive injections of PPA and l-NOR (1 mg/kg, 4 doses at 5-min intervals) failed to produce tachyphylaxis to the pressor response. On the other hand, when d-NORP was administered in a similar fashion, tachyphylaxis to the second and subsequent doses was observed. These studies demonstrate that significant mechanistic differences exist between these norephedrine isomers.
AuthorsF A Moya-Huff, P J Kiritsy, T J Maher
JournalJournal of pharmaceutical sciences (J Pharm Sci) Vol. 76 Issue 2 Pg. 114-6 (Feb 1987) ISSN: 0022-3549 [Print] United States
PMID3572747 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • norpseudoephedrine
  • Phenylpropanolamine
  • Reserpine
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Dose-Response Relationship, Drug
  • Male
  • Optical Rotation
  • Phenylpropanolamine (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Reserpine (pharmacology)
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: